Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.21 is 50% above its 3-year average of 0.80, near the high end of its 3-year range (-0.03–1.52).
As of the fiscal period ended Wednesday, December 31, 2025. 17.97% below its 12-month average of 1.48.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 3 quarters.
EARNINGS PER SHARE (EPS)
1.21
EARNINGS PER SHARE (EPS) AVG TTM
1.48
EARNINGS PER SHARE (EPS) AVG 3Y
0.80
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.97%
CURRENT VS 3Y AVG
+50.39%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$30.74B
Earnings Per Share (EPS)
-10.44
TTM Avg
-3.64
3Y Avg
-0.05
5Y Avg
0.88
Market Cap
$30.72B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$29.99B
Earnings Per Share (EPS)
151.44
TTM Avg
10.02
3Y Avg
12.26
5Y Avg
14.06
Market Cap
$28.62B
Earnings Per Share (EPS)
44.51
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$38.68B
Earnings Per Share (EPS)
8.06
TTM Avg
7.74
3Y Avg
7.17
5Y Avg
5.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $33.22B | 1.21 | 1.48 | 0.80 | N/A |
| Zoetis Inc. (ZTS)vs › | $32.40B | 6.03 | 5.75 | 5.27 | 4.80 |
| DexCom, Inc. (DXCM)vs › | $32.20B | 2.53 | 1.80 | 1.48 | 1.30 |
| Centene Corp. (CNC)vs › | $30.74B | -10.44 | -3.64 | -0.05 | 0.88 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 3.45 | 4.46 | 4.05 | 4.25 |
| ResMed Inc. (RMD)vs › | $30.60B | 10.34 | 8.25 | 6.99 | 5.92 |
| Biogen Inc. (BIIB)vs › | $29.99B | 151.44 | 10.02 | 12.26 | 14.06 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 44.51 | 41.42 | 39.43 | 36.04 |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 8.06 | 7.74 | 7.17 | 5.87 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.44B | 5.92 | 0.10 | -3.15 | -4.54 |
Trailing EPS (TTM)
$1.21
Forward EPS (Est.)
$1.51
P/E Ratio
32.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 1.43 |
| 2024-12-31 | 1.52 |
| 2023-12-31 | 0.30 |
| 2022-12-31 | -0.03 |
